Market Overview:
The global tissue engineered products (TEP) market is expected to reach USD 9.8 billion by 2030, according to a new study by Grand View Research, Inc. The increasing incidence of chronic diseases and the subsequent rise in demand for organ transplants are key factors propelling the growth of the TEP market. In addition, technological advancements in tissue engineering are anticipated to boost the demand for TEP over the forecast period. The global Tissue Engineered Skin (TES) market is estimated to account for a revenue share of over 60% by 2030 owing to its high adoption rate across various applications such as burns, skin grafts, and reconstructive surgeries. The increasing prevalence of skin disorders and rising awareness about advanced treatment options are some major factors driving the growth of this segment. Furthermore, growing investments in research & development activities aimed at developing novel TES products is likely to propel this segment’s growth during the forecast period. Oncology accounted for majority share (~40%)of total tissue-engineered medicines (TEM) revenue generated in 2017 on account of its high adoption rates across various application segments such as cancer diagnosis & treatment and regenerative medicine therapies. Moreover, favorable reimbursement policies coupled with rising incidence rates of cancer worldwide are expected to drive demand for oncology-based TEM products over next decade .
 Industry Outlook.svg)
Product Definition:
Tissue engineered products (TEP) are biomaterial-based products that have been designed to replace or support the function of tissues and organs. Tissue engineering is a relatively new field that has the potential to revolutionize medicine by regenerating damaged tissues and organs. Tissue engineered products can be used for a variety of applications, including wound healing, tissue repair, organ replacement, and drug delivery.
Tissue Engineered Skin:
Tissue engineered skin (TES) is a procedure wherein the patient's own cells are used to stimulate the growth of new tissue which in turn is used for reconstruction or repair of damaged areas. The process involves extracting small samples from the patient's body and using it to create new tissue with high precision. This newly created tissue is then transplanted onto areas which need reconstruction or repair.
Tissue Engineered Bones:
Tissue engineered bones have the ability to grow and repair bone tissue in the absence of natural bone formation. These are being studied as a potential source for TEPs since they can be readily used in surgical procedures, which currently use implants that do not match well with native architecture of the body.
The global market size was valued at USD 1.6 billion in 2016.
Application Insights:
The hospital application segment led the global tissue engineered products market in 2017. The segment will expand further at a steady CAGR over the forecast period owing to an increase in demand for advanced TEPs that are used to treat life-threatening conditions. For instance, Stem Cells International Corporation¢â‚¬â„¢s (SCIC) BioScaffold Platform has been widely adopted by research laboratories and hospitals worldwide for regenerative medicine applications. This platform offers a variety of product types that are used for various clinical needs such as bone, cartilage, tendons & ligaments and soft tissue repair & reconstruction.
Clinical trials accounted for 29% of the revenue share generated by clinic applications in 2017 due to increasing utilization of TEPs across different disease categories such as cardiovascular, orthopedic trauma and arthritis as well as neurological disorders such as Parkinson¢â‚¬â„¢s disease.
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to the presence of a large number of players, high investment in R&D and availability of reimbursement facilities for clinical trials. The U.S., which accounted for majority share is expected to grow at a significant rate during the forecast period due to increasing cases of osteoporosis and other bone-related disorders that can be treated by using TEPs products such as engineered bone grafts, porous ceramic materials etc.
Growth Factors:
- Increasing demand for minimally invasive surgeries: Tissue engineered products are finding increasing application in minimally invasive surgeries. This is because these products help reduce surgical trauma, speed up the healing process and improve the overall outcome of the surgery.
- Growing prevalence of chronic diseases: The incidence of chronic diseases such as cancer, heart disease and diabetes is on the rise globally. This is leading to an increase in demand for tissue engineered products that can be used for treatment or prevention of these diseases.
- Advances in tissue engineering technology: The field of tissue engineering is constantly evolving with new advances being made in technology and materials science. This is helping to boost the growth prospects of the TEP market worldwide.
Scope Of The Report
Report Attributes
Report Details
Report Title
Tissue Engineered Products (TEP) Market Research Report
By Type
Tissue Engineered Skin, Tissue Engineered Bones, Tissue-engineered Medicines
By Application
Hospital, Clinic
By Companies
Amarantus BioScience Holdings, Acelity L.P., Inc., BSN medical, Integra LifeSciences Corporation, Medtronic (Covidien), Molnlycke Health Care, Smith & Nephew plc, Organogenesis, Inc, Johnson & Johnson, Stryker, Zimmer Biomet, Medtronic, Invibio, Allograft Tissue Systems, Inc, Alphatec Spine, Inc, BioMimetic Therapeutics, Inc, CAM Bioceramics, CeraPedics LLC, Segment by Type, Inorganic Material, Organic Material, Composite Material
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
130
Number of Tables & Figures
91
Customization Available
Yes, the report can be customized as per your need.
Global Tissue Engineered Products (TEP) Market Report Segments:
The global Tissue Engineered Products (TEP) market is segmented on the basis of:
Types
Tissue Engineered Skin, Tissue Engineered Bones, Tissue-engineered Medicines
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Clinic
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Amarantus BioScience Holdings
- Acelity L.P., Inc.
- BSN medical
- Integra LifeSciences Corporation
- Medtronic (Covidien)
- Molnlycke Health Care
- Smith & Nephew plc
- Organogenesis, Inc
- Johnson & Johnson
- Stryker
- Zimmer Biomet
- Medtronic
- Invibio
- Allograft Tissue Systems, Inc
- Alphatec Spine, Inc
- BioMimetic Therapeutics, Inc
- CAM Bioceramics
- CeraPedics LLC
- Segment by Type
- Inorganic Material
- Organic Material
- Composite Material
 Market Overview.svg)
Highlights of The Tissue Engineered Products (TEP) Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Tissue Engineered Skin
- Tissue Engineered Bones
- Tissue-engineered Medicines
- By Application:
- Hospital
- Clinic
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Tissue Engineered Products (TEP) Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
 Market Statistics.svg)
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Tissue Engineered Products (TEP) are products that have been engineered from human cells and tissues. TEPs can be used in a variety of applications, including medical devices, pharmaceuticals, and materials.
Some of the major players in the tissue engineered products (tep) market are Amarantus BioScience Holdings, Acelity L.P., Inc., BSN medical, Integra LifeSciences Corporation, Medtronic (Covidien), Molnlycke Health Care, Smith & Nephew plc, Organogenesis, Inc, Johnson & Johnson, Stryker, Zimmer Biomet, Medtronic, Invibio, Allograft Tissue Systems, Inc, Alphatec Spine, Inc, BioMimetic Therapeutics, Inc, CAM Bioceramics, CeraPedics LLC, Segment by Type, Inorganic Material, Organic Material, Composite Material.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Tissue Engineered Products (TEP) Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Tissue Engineered Products (TEP) Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Tissue Engineered Products (TEP) Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Tissue Engineered Products (TEP) Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Tissue Engineered Products (TEP) Market Size & Forecast, 2018-2028
4.5.1 Tissue Engineered Products (TEP) Market Size and Y-o-Y Growth
4.5.2 Tissue Engineered Products (TEP) Market Absolute $ Opportunity
Chapter 5 Global Tissue Engineered Products (TEP) Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Tissue Engineered Products (TEP) Market Size Forecast by Type
5.2.1 Tissue Engineered Skin
5.2.2 Tissue Engineered Bones
5.2.3 Tissue-engineered Medicines
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Tissue Engineered Products (TEP) Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Tissue Engineered Products (TEP) Market Size Forecast by Applications
6.2.1 Hospital
6.2.2 Clinic
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Tissue Engineered Products (TEP) Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Tissue Engineered Products (TEP) Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Tissue Engineered Products (TEP) Analysis and Forecast
9.1 Introduction
9.2 North America Tissue Engineered Products (TEP) Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Tissue Engineered Products (TEP) Market Size Forecast by Type
9.6.1 Tissue Engineered Skin
9.6.2 Tissue Engineered Bones
9.6.3 Tissue-engineered Medicines
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Tissue Engineered Products (TEP) Market Size Forecast by Applications
9.10.1 Hospital
9.10.2 Clinic
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Tissue Engineered Products (TEP) Analysis and Forecast
10.1 Introduction
10.2 Europe Tissue Engineered Products (TEP) Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Tissue Engineered Products (TEP) Market Size Forecast by Type
10.6.1 Tissue Engineered Skin
10.6.2 Tissue Engineered Bones
10.6.3 Tissue-engineered Medicines
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Tissue Engineered Products (TEP) Market Size Forecast by Applications
10.10.1 Hospital
10.10.2 Clinic
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Tissue Engineered Products (TEP) Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Tissue Engineered Products (TEP) Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Tissue Engineered Products (TEP) Market Size Forecast by Type
11.6.1 Tissue Engineered Skin
11.6.2 Tissue Engineered Bones
11.6.3 Tissue-engineered Medicines
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Tissue Engineered Products (TEP) Market Size Forecast by Applications
11.10.1 Hospital
11.10.2 Clinic
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Tissue Engineered Products (TEP) Analysis and Forecast
12.1 Introduction
12.2 Latin America Tissue Engineered Products (TEP) Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Tissue Engineered Products (TEP) Market Size Forecast by Type
12.6.1 Tissue Engineered Skin
12.6.2 Tissue Engineered Bones
12.6.3 Tissue-engineered Medicines
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Tissue Engineered Products (TEP) Market Size Forecast by Applications
12.10.1 Hospital
12.10.2 Clinic
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Tissue Engineered Products (TEP) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Tissue Engineered Products (TEP) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Tissue Engineered Products (TEP) Market Size Forecast by Type
13.6.1 Tissue Engineered Skin
13.6.2 Tissue Engineered Bones
13.6.3 Tissue-engineered Medicines
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Tissue Engineered Products (TEP) Market Size Forecast by Applications
13.10.1 Hospital
13.10.2 Clinic
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Tissue Engineered Products (TEP) Market: Competitive Dashboard
14.2 Global Tissue Engineered Products (TEP) Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Amarantus BioScience Holdings
14.3.2 Acelity L.P., Inc.
14.3.3 BSN medical
14.3.4 Integra LifeSciences Corporation
14.3.5 Medtronic (Covidien)
14.3.6 Molnlycke Health Care
14.3.7 Smith & Nephew plc
14.3.8 Organogenesis, Inc
14.3.9 Johnson & Johnson
14.3.10 Stryker
14.3.11 Zimmer Biomet
14.3.12 Medtronic
14.3.13 Invibio
14.3.14 Allograft Tissue Systems, Inc
14.3.15 Alphatec Spine, Inc
14.3.16 BioMimetic Therapeutics, Inc
14.3.17 CAM Bioceramics
14.3.18 CeraPedics LLC
14.3.19 Segment by Type
14.3.20 Inorganic Material
14.3.21 Organic Material
14.3.22 Composite Material
